🇺🇸 FDA
Pipeline program

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

SHC02

Approved mab completed

Quick answer

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell for Cholera is a Approved program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Cholera
Phase
Approved
Modality
mab
Status
completed

Clinical trials